-
1
-
-
4344685290
-
Signs and symptoms of thin basement membrane nephropathy: A prospective regional study on primary glomerular disease-the limburg renal registry
-
van Paassen P, van Breda Vriesman PJ, van Rie H, et al. Signs and symptoms of thin basement membrane nephropathy: a prospective regional study on primary glomerular disease-The Limburg Renal Registry. Kidney Int 2004;66(3):909-13
-
(2004)
Kidney Int
, vol.66
, Issue.3
, pp. 909-913
-
-
Van Paassen, P.1
Van Breda Vriesman, P.J.2
Van Rie, H.3
-
2
-
-
23944452434
-
Management of membranous nephropathy: When and what for treatment
-
Cattran D. Management of membranous nephropathy: when and what for treatment. J Am Soc Nephrol 2005;16(5):1188-94
-
(2005)
J Am Soc Nephrol
, vol.16
, Issue.5
, pp. 1188-1194
-
-
Cattran, D.1
-
3
-
-
0018133117
-
Experimental glomerulonephritis in the isolated perfused rat kidney
-
Couser WG, Steinmuller DR, Stilmant MM, et al. Experimental glomerulonephritis in the isolated perfused rat kidney. J Clin Invest 1978;62(6): 1275-87
-
(1978)
J Clin Invest
, vol.62
, Issue.6
, pp. 1275-1287
-
-
Couser, W.G.1
Steinmuller, D.R.2
Stilmant, M.M.3
-
4
-
-
0018825265
-
In situ immune complex formation and glomerular injury
-
Couser WG, Salant DJ. In situ immune complex formation and glomerular injury. Kidney Int 1980;17(1):1-13
-
(1980)
Kidney Int
, vol.17
, Issue.1
, pp. 1-13
-
-
Couser, W.G.1
Salant, D.J.2
-
5
-
-
0032920291
-
Complement-mediated injury reversibly disrupts glomerular epithelial cell actin microfilaments and focal adhesions
-
Topham PS, Haydar SA, Kuphal R, et al. Complement-mediated injury reversibly disrupts glomerular epithelial cell actin microfilaments and focal adhesions. Kidney Int 1999;55(5):1763-75
-
(1999)
Kidney Int
, vol.55
, Issue.5
, pp. 1763-1775
-
-
Topham, P.S.1
Haydar, S.A.2
Kuphal, R.3
-
6
-
-
0344708488
-
Complement mediates nephrin redistribution and actin dissociation in experimental membranous nephropathy
-
Saran AM, Yuan H, Takeuchi E, et al. Complement mediates nephrin redistribution and actin dissociation in experimental membranous nephropathy. Kidney Int 2003;64(6):2072-8
-
(2003)
Kidney Int
, vol.64
, Issue.6
, pp. 2072-2078
-
-
Saran, A.M.1
Yuan, H.2
Takeuchi, E.3
-
7
-
-
67649658244
-
M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy
-
Beck LH Jr, Bonegio RG, Lambeau G, et al. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med 2009;361(1): 11-21
-
(2009)
N Engl J Med
, vol.361
, Issue.1
, pp. 11-21
-
-
Beck, L.H.1
Bonegio, R.G.2
Lambeau, G.3
-
8
-
-
79951827439
-
Risk hla-dqa1 and pla(2) r1 alleles in idiopathic membranous nephropathy
-
Stanescu HC, Arcos-Burgos M, Medlar A, et al. Risk HLA-DQA1 and PLA(2) R1 alleles in idiopathic membranous nephropathy. N Engl J Med 2011;364(7): 616-26
-
(2011)
N Engl J Med
, vol.364
, Issue.7
, pp. 616-626
-
-
Stanescu, H.C.1
Arcos-Burgos, M.2
Medlar, A.3
-
9
-
-
84923919539
-
Identification of the immunodominant epitope region in phospholipase a2 receptor-mediating autoantibody binding in idiopathic membranous nephropathy
-
Kao L, Lam V, Waldman M, et al. Identification of the immunodominant epitope region in phospholipase a2 receptor-mediating autoantibody binding in idiopathic membranous nephropathy. J Am Soc Nephrol 2015;26(2):291-301
-
(2015)
J Am Soc Nephrol
, vol.26
, Issue.2
, pp. 291-301
-
-
Kao, L.1
Lam, V.2
Waldman, M.3
-
10
-
-
84875702300
-
Phospholipase a2 receptor (pla2r1) sequence variants in idiopathic membranous nephropathy
-
Coenen MJ, Hofstra JM, Debiec H, et al. Phospholipase A2 receptor (PLA2R1) sequence variants in idiopathic membranous nephropathy. J Am Soc Nephrol 2013; 24(4):677-83
-
(2013)
J Am Soc Nephrol
, vol.24
, Issue.4
, pp. 677-683
-
-
Coenen, M.J.1
Hofstra, J.M.2
Debiec, H.3
-
11
-
-
84881117530
-
Interaction between pla2r1 and hla-dqa1 variants associates with anti-pla2r antibodies and membranous nephropathy
-
Lv J, Hou W, Zhou X, et al. Interaction between PLA2R1 and HLA-DQA1 variants associates with anti-PLA2R antibodies and membranous nephropathy. J Am Soc Nephrol 2013;24(8):1323-9
-
(2013)
J Am Soc Nephrol
, vol.24
, Issue.8
, pp. 1323-1329
-
-
Lv, J.1
Hou, W.2
Zhou, X.3
-
12
-
-
79961085790
-
An immunofluorescence test for phospholipase- A(2)-receptor antibodies and its clinical usefulness in patients with membranous glomerulonephritis
-
Hoxha E, Harendza S, Zahner G, et al. An immunofluorescence test for phospholipase- A(2)-receptor antibodies and its clinical usefulness in patients with membranous glomerulonephritis. Nephrol Dial Transplant 2011;26(8):2526-32
-
(2011)
Nephrol Dial Transplant
, vol.26
, Issue.8
, pp. 2526-2532
-
-
Hoxha, E.1
Harendza, S.2
Zahner, G.3
-
13
-
-
84876441600
-
Development of a standardized elisa for the determination of autoantibodies against human m-type phospholipase a2 receptor in primary membranous nephropathy
-
Dahnrich C, Komorowski L, Probst C, et al. Development of a standardized ELISA for the determination of autoantibodies against human M-type phospholipase A2 receptor in primary membranous nephropathy. Clin Chim Acta 2013;421:213-18
-
(2013)
Clin Chim Acta
, vol.421
, pp. 213-218
-
-
Dahnrich, C.1
Komorowski, L.2
Probst, C.3
-
14
-
-
84904571214
-
Evaluation of anti-pla2r1 as measured by a novel elisa in patients with idiopathic membranous nephropathy: A cohort study
-
Timmermans SAMEG, Damoiseaux JG, Heerings-Rewinkel PT, et al. Evaluation of anti-PLA2R1 as measured by a novel ELISA in patients with idiopathic membranous nephropathy: a cohort study. Am J Clin Pathol 2014;142(1):29-34
-
(2014)
Am J Clin Pathol
, vol.142
, Issue.1
, pp. 29-34
-
-
Timmermans, S.A.M.E.G.1
Damoiseaux, J.G.2
Heerings-Rewinkel, P.T.3
-
15
-
-
79951819917
-
PLA2R autoantibodies and PLA2R glomerular deposits in membranous nephropathy
-
Debiec H, Ronco P. PLA2R autoantibodies and PLA2R glomerular deposits in membranous nephropathy. N Engl J Med 2011;364(7):689-90
-
(2011)
N Engl J Med
, vol.364
, Issue.7
, pp. 689-690
-
-
Debiec, H.1
Ronco, P.2
-
16
-
-
84884524462
-
Kidney biopsy is a sensitive tool for retrospective diagnosis of PLA2R-related membranous nephropathy
-
Svobodova B, Honsova E, Ronco P, et al. Kidney biopsy is a sensitive tool for retrospective diagnosis of PLA2R-related membranous nephropathy. Nephrol Dial Transplant 2013;28(7):1839-44
-
(2013)
Nephrol Dial Transplant
, vol.28
, Issue.7
, pp. 1839-1844
-
-
Svobodova, B.1
Honsova, E.2
Ronco, P.3
-
17
-
-
79957745793
-
Anti-phospholipase A2 receptor antibody in membranous nephropathy
-
Qin W, Beck LH Jr, Zeng C, et al. Anti-phospholipase A2 receptor antibody in membranous nephropathy. J Am Soc Nephrol 2011;22(6):1137-43
-
(2011)
J Am Soc Nephrol
, vol.22
, Issue.6
, pp. 1137-1143
-
-
Qin, W.1
Beck, L.H.2
Zeng, C.3
-
18
-
-
84877085738
-
Determination of primary versus secondary membranous glomerulopathy utilizing phospholipase A2 receptor staining in renal biopsies
-
Larsen CP, Messias NC, Silva FG, et al. Determination of primary versus secondary membranous glomerulopathy utilizing phospholipase A2 receptor staining in renal biopsies. Mod Pathol 2013;26(5):709-15
-
(2013)
Mod Pathol
, vol.26
, Issue.5
, pp. 709-715
-
-
Larsen, C.P.1
Messias, N.C.2
Silva, F.G.3
-
19
-
-
84866422732
-
Enhanced expression of the M-type phospholipase A2 receptor in glomeruli correlates with serum receptor antibodies in primary membranous nephropathy
-
Hoxha E, Kneissler U, Stege G, et al. Enhanced expression of the M-type phospholipase A2 receptor in glomeruli correlates with serum receptor antibodies in primary membranous nephropathy. Kidney Int 2012;82(7):797-804
-
(2012)
Kidney Int
, vol.82
, Issue.7
, pp. 797-804
-
-
Hoxha, E.1
Kneissler, U.2
Stege, G.3
-
20
-
-
84866119996
-
Coexistence of different circulating anti-podocyte antibodies in membranous nephropathy
-
Murtas C, Bruschi M, Candiano G, et al. Coexistence of different circulating anti-podocyte antibodies in membranous nephropathy. Clin J Am Soc Nephrol 2012; 7(9):1394-400
-
(2012)
Clin J Am Soc Nephrol
, vol.7
, Issue.9
, pp. 1394-1400
-
-
Murtas, C.1
Bruschi, M.2
Candiano, G.3
-
21
-
-
84918548245
-
Thrombospondin type-1 domain-containing 7a in idiopathic membranous nephropathy
-
Tomas NM, Beck LH Jr, Meyer-Schwesinger C, et al. Thrombospondin type-1 domain-containing 7a in idiopathic membranous nephropathy. N Engl J Med 2014;371(24):2277-87
-
(2014)
N Engl J Med
, vol.371
, Issue.24
, pp. 2277-2287
-
-
Tomas, N.M.1
Beck, L.H.2
Meyer-Schwesinger, C.3
-
22
-
-
0018397339
-
Long-term prognosis of idiopathic membranous glomerulonephritis study of 116 untreated patients
-
Noel LH, Zanetti M, Droz D, et al. Long-term prognosis of idiopathic membranous glomerulonephritis. Study of 116 untreated patients. Am J Med 1979; 66(1):82-90
-
(1979)
Am J Med
, vol.66
, Issue.1
, pp. 82-90
-
-
Noel, L.H.1
Zanetti, M.2
Droz, D.3
-
23
-
-
83155182239
-
Low-molecular-weight proteins as prognostic markers in idiopathic membranous nephropathy
-
van Den Brand JA, Hofstra JM, Wetzels JF. Low-molecular-weight proteins as prognostic markers in idiopathic membranous nephropathy. Clin J Am Soc Nephrol 2011; 6(12):2846-53
-
(2011)
Clin J Am Soc Nephrol
, vol.6
, Issue.12
, pp. 2846-2853
-
-
Van Den Brand, J.A.1
Hofstra, J.M.2
Wetzels, J.F.3
-
24
-
-
0028785260
-
A 10-year follow-up of a randomized study with methylprednisolone and chlorambucil in membranous nephropathy
-
Ponticelli C, Zucchelli P, Passerini P, et al. A 10-year follow-up of a randomized study with methylprednisolone and chlorambucil in membranous nephropathy. Kidney Int 1995;48(5):1600-4
-
(1995)
Kidney Int
, vol.48
, Issue.5
, pp. 1600-1604
-
-
Ponticelli, C.1
Zucchelli, P.2
Passerini, P.3
-
25
-
-
34249894713
-
A randomized, controlled trial of steroids and cyclophosphamide in adults with nephrotic syndrome caused by idiopathic membranous nephropathy
-
Jha V, Ganguli A, Saha TK, et al. A randomized, controlled trial of steroids and cyclophosphamide in adults with nephrotic syndrome caused by idiopathic membranous nephropathy. J Am Soc Nephrol 2007;18(6):1899-904
-
(2007)
J Am Soc Nephrol
, vol.18
, Issue.6
, pp. 1899-1904
-
-
Jha, V.1
Ganguli, A.2
Saha, T.K.3
-
26
-
-
85096618679
-
Chapter 7: Idiopathic membranous nephropathy
-
Kidney Disease improving Global Outcomes (KDIGO) Glomerulonephritis Work Group
-
Kidney Disease: improving Global Outcomes (KDIGO) Glomerulonephritis Work Group. Chapter 7: idiopathic membranous nephropathy. Kidney Int Suppl 2012;2(2):186-97
-
(2012)
Kidney Int Suppl
, vol.2
, Issue.2
, pp. 186-197
-
-
-
27
-
-
79958186439
-
Anti-phospholipase A(2) receptor antibodies correlate with clinical status in idiopathic membranous nephropathy
-
Hofstra JM, Beck LH Jr, Beck DM, et al. Anti-phospholipase A(2) receptor antibodies correlate with clinical status in idiopathic membranous nephropathy. Clin J Am Soc Nephrol 2011;6(6):1286-91
-
(2011)
Clin J Am Soc Nephrol
, vol.6
, Issue.6
, pp. 1286-1291
-
-
Hofstra, J.M.1
Beck, L.H.2
Beck, D.M.3
-
28
-
-
84877023060
-
Anti-pla2r antibodies measured by elisa predict long-term outcome in a prevalent population of patients with idiopathic membranous nephropathy
-
Kanigicherla D, Gummadova J, McKenzie EA, et al. Anti-PLA2R antibodies measured by ELISA predict long-term outcome in a prevalent population of patients with idiopathic membranous nephropathy. Kidney Int 2013;83(5):940-8
-
(2013)
Kidney Int
, vol.83
, Issue.5
, pp. 940-948
-
-
Kanigicherla, D.1
Gummadova, J.2
McKenzie, E.A.3
-
29
-
-
84867153044
-
Antiphospholipase A2 receptor antibody titer and subclass in idiopathic membranous nephropathy
-
Hofstra JM, Debiec H, Short CD, et al. Antiphospholipase A2 receptor antibody titer and subclass in idiopathic membranous nephropathy. J Am Soc Nephrol 2012; 23(10):1735-43
-
(2012)
J Am Soc Nephrol
, vol.23
, Issue.10
, pp. 1735-1743
-
-
Hofstra, J.M.1
Debiec, H.2
Short, C.D.3
-
30
-
-
84923930941
-
M-type phospholipase a2 receptor autoantibodies and renal function in patients with primary membranous nephropathy
-
Hoxha E, Harendza S, Pinnschmidt H, et al. M-type phospholipase a2 receptor autoantibodies and renal function in patients with primary membranous nephropathy. Clin J Am Soc Nephrol 2014; 9(11):1883-90
-
(2014)
Clin J Am Soc Nephrol
, vol.9
, Issue.11
, pp. 1883-1890
-
-
Hoxha, E.1
Harendza, S.2
Pinnschmidt, H.3
-
31
-
-
79960948754
-
Rituximab-induced depletion of anti-pla2r autoantibodies predicts response in membranous nephropathy
-
Beck LH Jr, Fervenza FC, Beck DM, et al. Rituximab-induced depletion of anti-PLA2R autoantibodies predicts response in membranous nephropathy. J Am Soc Nephrol 2011;22(8):1543-50
-
(2011)
J Am Soc Nephrol
, vol.22
, Issue.8
, pp. 1543-1550
-
-
Beck, L.H.1
Fervenza, F.C.2
Beck, D.M.3
-
32
-
-
84906088212
-
Phospholipase A2 receptor autoantibodies and clinical outcome in patients with primary membranous nephropathy
-
Hoxha E, Thiele I, Zahner G, et al. Phospholipase A2 receptor autoantibodies and clinical outcome in patients with primary membranous nephropathy. J Am Soc Nephrol 2014;25(6):1357-66
-
(2014)
J Am Soc Nephrol
, vol.25
, Issue.6
, pp. 1357-1366
-
-
Hoxha, E.1
Thiele, I.2
Zahner, G.3
-
33
-
-
84921798402
-
Association of anti-PLA(2)R antibodies with outcomes after immunosuppressive therapy in idiopathic membranous nephropathy
-
Bech AP, Hofstra JM, Brenchley PE, et al. Association of anti-PLA(2)R antibodies with outcomes after immunosuppressive therapy in idiopathic membranous nephropathy. Clin J Am Soc Nephrol 2014;9(8):1386-92
-
(2014)
Clin J Am Soc Nephrol
, vol.9
, Issue.8
, pp. 1386-1392
-
-
Bech, A.P.1
Hofstra, J.M.2
Brenchley, P.E.3
-
34
-
-
84874401903
-
Immunosuppression for progressive membranous nephropathy: A UK randomised controlled trial
-
Howman A, Chapman TL, Langdon MM, et al. Immunosuppression for progressive membranous nephropathy: a UK randomised controlled trial. Lancet 2013; 381(9868):744-51
-
(2013)
Lancet
, vol.381
, Issue.9868
, pp. 744-751
-
-
Howman, A.1
Chapman, T.L.2
Langdon, M.M.3
-
35
-
-
84864833114
-
Rituximab in idiopathic membranous nephropathy
-
Ruggenenti P, Cravedi P, Chianca A, et al. Rituximab in idiopathic membranous nephropathy. J Am Soc Nephrol 2012; 23(8):1416-25
-
(2012)
J Am Soc Nephrol
, vol.23
, Issue.8
, pp. 1416-1425
-
-
Ruggenenti, P.1
Cravedi, P.2
Chianca, A.3
-
36
-
-
84899943190
-
Genetic testing for nephrotic syndrome and FSGS in the era of next-generation sequencing
-
Brown EJ, Pollak MR, Barua M. Genetic testing for nephrotic syndrome and FSGS in the era of next-generation sequencing. Kidney Int 2014;85(5):1030-8
-
(2014)
Kidney Int
, vol.85
, Issue.5
, pp. 1030-1038
-
-
Brown, E.J.1
Pollak, M.R.2
Barua, M.3
-
37
-
-
85096381157
-
Chapter 6: Idiopathic focal segmental glomerulosclerosis in adults
-
Kidney Disease improving Glonal Outcomes (KDIGO) Glomerulonephritis Work Group
-
Kidney Disease: improving Glonal Outcomes (KDIGO) Glomerulonephritis Work Group. Chapter 6: idiopathic focal segmental glomerulosclerosis in adults. Kidney Int Suppl 2012;2(2):181-5
-
(2012)
Kidney Int Suppl
, vol.2
, Issue.2
, pp. 181-185
-
-
-
38
-
-
13344285352
-
Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis
-
Savin VJ, Sharma R, Sharma M, et al. Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis. N Engl J Med 1996;334(14):878-83
-
(1996)
N Engl J Med
, vol.334
, Issue.14
, pp. 878-883
-
-
Savin, V.J.1
Sharma, R.2
Sharma, M.3
-
39
-
-
0033052191
-
The FSGS factor: Enrichment and in vivo effect of activity from focal segmental glomerulosclerosis plasma
-
Sharma M, Sharma R, McCarthy ET, Savin VJ. The FSGS factor: enrichment and in vivo effect of activity from focal segmental glomerulosclerosis plasma. J Am Soc Nephrol 1999;10(3):552-61
-
(1999)
J Am Soc Nephrol
, vol.10
, Issue.3
, pp. 552-561
-
-
Sharma, M.1
Sharma, R.2
McCarthy, E.T.3
Savin, V.J.4
-
40
-
-
0035253559
-
Transmission of glomerular permeability factor from a mother to her child
-
Kemper MJ, Wolf G, Müller-Wiefel DE. Transmission of glomerular permeability factor from a mother to her child. N Engl J Med 2001;344(5):386-7
-
(2001)
N Engl J Med
, vol.344
, Issue.5
, pp. 386-387
-
-
Kemper, M.J.1
Wolf, G.2
Müller-Wiefel, D.E.3
-
41
-
-
84872354111
-
Transmission of glomerular permeability factor soluble urokinase plasminogen activator receptor (supar) from a mother to child
-
Kemper MJ, Wei C, Reiser J. Transmission of glomerular permeability factor soluble urokinase plasminogen activator receptor (suPAR) from a mother to child. Am J Kidney Dis 2013;61(2):352
-
(2013)
Am J Kidney Dis
, vol.61
, Issue.2
, pp. 352
-
-
Kemper, M.J.1
Wei, C.2
Reiser, J.3
-
42
-
-
79961132981
-
Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis
-
Wei C, El Hindi S, Li J, et al. Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis. Nat Med 2011;17(8):952-60
-
(2011)
Nat Med
, vol.17
, Issue.8
, pp. 952-960
-
-
Wei, C.1
El Hindi, S.2
Li, J.3
-
43
-
-
84870546490
-
Circulating suPAR in two cohorts of primary FSGS
-
Wei C, Trachtman H, Li J, et al. Circulating suPAR in two cohorts of primary FSGS. J Am Soc Nephrol 2012; 23(12):2051-9
-
(2012)
J Am Soc Nephrol
, vol.23
, Issue.12
, pp. 2051-2059
-
-
Wei, C.1
Trachtman, H.2
Li, J.3
-
44
-
-
84895155571
-
The soluble urokinase receptor is not a clinical marker for focal segmental glomerulosclerosis
-
Meijers B, Maas RJ, Sprangers B, et al. The soluble urokinase receptor is not a clinical marker for focal segmental glomerulosclerosis. Kidney Int 2014;85(3): 636-40
-
(2014)
Kidney Int
, vol.85
, Issue.3
, pp. 636-640
-
-
Meijers, B.1
Maas, R.J.2
Sprangers, B.3
-
45
-
-
84881244297
-
Serum soluble urokinase-type plasminogen activator receptor levels and idiopathic fsgs in children: A single-center report
-
Bock ME, Price HE, Gallon L, et al. Serum soluble urokinase-type plasminogen activator receptor levels and idiopathic FSGS in children: a single-center report. Clin J Am Soc Nephrol 2013;8(8):1304-11
-
(2013)
Clin J Am Soc Nephrol
, vol.8
, Issue.8
, pp. 1304-1311
-
-
Bock, M.E.1
Price, H.E.2
Gallon, L.3
-
46
-
-
34748843166
-
A proposed taxonomy for the podocytopathies: A reassessment of the primary nephrotic diseases
-
Barisoni L, Schnaper HW, Kopp JB. A proposed taxonomy for the podocytopathies: a reassessment of the primary nephrotic diseases. Clin J Am Soc Nephrol 2007;2(3):529-42
-
(2007)
Clin J Am Soc Nephrol
, vol.2
, Issue.3
, pp. 529-542
-
-
Barisoni, L.1
Schnaper, H.W.2
Kopp, J.B.3
-
47
-
-
59949099339
-
Urinary CD80 excretion increases in idiopathic minimal-change disease
-
Garin EH, Diaz LN, Mu W, et al. Urinary CD80 excretion increases in idiopathic minimal-change disease. J Am Soc Nephrol 2009;20(2):260-6
-
(2009)
J Am Soc Nephrol
, vol.20
, Issue.2
, pp. 260-266
-
-
Garin, E.H.1
Diaz, L.N.2
Mu, W.3
-
48
-
-
77954733049
-
Urinary CD80 is elevated in minimal change disease but not in focal segmental glomerulosclerosis
-
Garin EH, Mu W, Arthur JM, et al. Urinary CD80 is elevated in minimal change disease but not in focal segmental glomerulosclerosis. Kidney Int 2010;78(3): 296-302
-
(2010)
Kidney Int
, vol.78
, Issue.3
, pp. 296-302
-
-
Garin, E.H.1
Mu, W.2
Arthur, J.M.3
-
49
-
-
34547815735
-
Podocyte protection by darbepoetin: Preservation of the cytoskeleton and nephrin expression
-
Eto N, Wada T, Inagi R, et al. Podocyte protection by darbepoetin: preservation of the cytoskeleton and nephrin expression. Kidney Int 2007;72(4):455-63
-
(2007)
Kidney Int
, vol.72
, Issue.4
, pp. 455-463
-
-
Eto, N.1
Wada, T.2
Inagi, R.3
-
50
-
-
84924964566
-
Case series: CTLA4-IgG1 therapy in minimal change disease and focal segmental glomerulosclerosis
-
Garin EH, Reiser J, Cara-Fuentes G, et al. Case series: CTLA4-IgG1 therapy in minimal change disease and focal segmental glomerulosclerosis. Pediatr Nephrol 2015; 30(3):469-77
-
(2015)
Pediatr Nephrol
, vol.30
, Issue.3
, pp. 469-477
-
-
Garin, E.H.1
Reiser, J.2
Cara-Fuentes, G.3
-
51
-
-
84925000866
-
Misdiagnosing renal amyloidosis as minimal change disease
-
Sayed RH, Gilbertson JA, Hutt DF, et al. Misdiagnosing renal amyloidosis as minimal change disease. Nephrol Dial Transplant 2014;29(11):2120-6
-
(2014)
Nephrol Dial Transplant
, vol.29
, Issue.11
, pp. 2120-2126
-
-
Sayed, R.H.1
Gilbertson, J.A.2
Hutt, D.F.3
-
52
-
-
84883674592
-
Renal amyloidosis: Origin and clinicopathologic correlations of 474 recent cases
-
Said SM, Sethi S, Valeri AM, et al. Renal amyloidosis: origin and clinicopathologic correlations of 474 recent cases. Clin J Am Soc Nephrol 2013;8(9):1515-23
-
(2013)
Clin J Am Soc Nephrol
, vol.8
, Issue.9
, pp. 1515-1523
-
-
Said, S.M.1
Sethi, S.2
Valeri, A.M.3
-
53
-
-
0028970456
-
Primary systemic amyloidosis: Clinical and laboratory features in 474 cases
-
Kyle RA, Gertz MA. Primary systemic amyloidosis: clinical and laboratory features in 474 cases. Semin Hematol 1995;32(1): 45-59
-
(1995)
Semin Hematol
, vol.32
, Issue.1
, pp. 45-59
-
-
Kyle, R.A.1
Gertz, M.A.2
-
54
-
-
84868157601
-
How i treat amyloidosis: The importance of accurate diagnosis and amyloid typing
-
Leung N, Nasr SH, Sethi S. How I treat amyloidosis: the importance of accurate diagnosis and amyloid typing. Blood 2012; 120(16):3206-13
-
(2012)
Blood
, vol.120
, Issue.16
, pp. 3206-3213
-
-
Leung, N.1
Nasr, S.H.2
Sethi, S.3
-
56
-
-
0029001438
-
Galactosylation of n- and o-linked carbohydrate moieties of iga1 and igg in iga nephropathy
-
Allen AC, Harper SJ, Feehally J. Galactosylation of N- and O-linked carbohydrate moieties of IgA1 and IgG in IgA nephropathy. Clin Exp Immunol 1995; 100(3):470-4
-
(1995)
Clin Exp Immunol
, vol.100
, Issue.3
, pp. 470-474
-
-
Allen, A.C.1
Harper, S.J.2
Feehally, J.3
-
57
-
-
67651006853
-
Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity
-
Suzuki H, Fan R, Zhang Z, et al. Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity. J Clin Invest 2009;119(6):1668-77
-
(2009)
J Clin Invest
, vol.119
, Issue.6
, pp. 1668-1677
-
-
Suzuki, H.1
Fan, R.2
Zhang, Z.3
-
58
-
-
34249099962
-
Iga nephropathy and henoch-schoenlein purpura nephritis: Aberrant glycosylation of iga1, formation of iga1-containing immune complexes, and activation of mesangial cells
-
Novak J, Moldoveanu Z, Renfrow MB, et al. IgA nephropathy and Henoch-Schoenlein purpura nephritis: aberrant glycosylation of IgA1, formation of IgA1-containing immune complexes, and activation of mesangial cells. Contrib Nephrol 2007;157:134-8
-
(2007)
Contrib Nephrol
, vol.157
, pp. 134-138
-
-
Novak, J.1
Moldoveanu, Z.2
Renfrow, M.B.3
-
59
-
-
84867164317
-
Long-term outcomes of IgA nephropathy presenting with minimal or no proteinuria
-
Gutierrez E, Zamora I, Ballarin JA, et al. Long-term outcomes of IgA nephropathy presenting with minimal or no proteinuria. J Am Soc Nephrol 2012;23(10):1753-60
-
(2012)
J Am Soc Nephrol
, vol.23
, Issue.10
, pp. 1753-1760
-
-
Gutierrez, E.1
Zamora, I.2
Ballarin, J.A.3
-
60
-
-
0035870771
-
The natural history of immunoglobulin a nephropathy among patients with hematuria and minimal proteinuria
-
Szeto CC, Lai FM, To KF, et al. The natural history of immunoglobulin a nephropathy among patients with hematuria and minimal proteinuria. Am J Med 2001; 110(6):434-7
-
(2001)
Am J Med
, vol.110
, Issue.6
, pp. 434-437
-
-
Szeto, C.C.1
Lai, F.M.2
To, K.F.3
-
61
-
-
46649106141
-
Clinical course and prognostic factors of clinical early IgA nephropathy
-
Shen P, He L, Huang D. Clinical course and prognostic factors of clinical early IgA nephropathy. Neth J Med 2008;66(6): 242-7
-
(2008)
Neth J Med
, vol.66
, Issue.6
, pp. 242-247
-
-
Shen, P.1
He, L.2
Huang, D.3
-
63
-
-
80051575524
-
Oxidative stress and galactose-deficient IgA1 as markers of progression in IgA nephropathy
-
Camilla R, Suzuki H, Dapra V, et al. Oxidative stress and galactose-deficient IgA1 as markers of progression in IgA nephropathy. Clin J Am Soc Nephrol 2011;6(8):1903-11
-
(2011)
Clin J Am Soc Nephrol
, vol.6
, Issue.8
, pp. 1903-1911
-
-
Camilla, R.1
Suzuki, H.2
Dapra, V.3
-
64
-
-
84866376076
-
The level of galactose-deficient IgA1 in the sera of patients with IgA nephropathy is associated with disease progression
-
Zhao N, Hou P, Lv J, et al. The level of galactose-deficient IgA1 in the sera of patients with IgA nephropathy is associated with disease progression. Kidney Int 2012; 82(7):790-6
-
(2012)
Kidney Int
, vol.82
, Issue.7
, pp. 790-796
-
-
Zhao, N.1
Hou, P.2
Lv, J.3
-
65
-
-
84865976351
-
Autoantibodies targeting galactose-deficient IgA1 associate with progression of IgA nephropathy
-
Berthoux F, Suzuki H, Thibaudin L, et al. Autoantibodies targeting galactose-deficient IgA1 associate with progression of IgA nephropathy. J Am Soc Nephrol 2012; 23(9):1579-87
-
(2012)
J Am Soc Nephrol
, vol.23
, Issue.9
, pp. 1579-1587
-
-
Berthoux, F.1
Suzuki, H.2
Thibaudin, L.3
-
66
-
-
84863576385
-
Urinary mannose-binding lectin is a biomarker for predicting the progression of immunoglobulin (Ig)A nephropathy
-
Liu LL, Jiang Y, Wang LN, et al. Urinary mannose-binding lectin is a biomarker for predicting the progression of immunoglobulin (Ig)A nephropathy. Clin Exp Immunol 2012;169(2):148-55
-
(2012)
Clin Exp Immunol
, vol.169
, Issue.2
, pp. 148-155
-
-
Liu, L.L.1
Jiang, Y.2
Wang, L.N.3
-
67
-
-
33646924264
-
Glomerular activation of the lectin pathway of complement in IgA nephropathy is associated with more severe renal disease
-
Roos A, Rastaldi MP, Calvaresi N, et al. Glomerular activation of the lectin pathway of complement in IgA nephropathy is associated with more severe renal disease. J Am Soc Nephrol 2006;17(6):1724-34
-
(2006)
J Am Soc Nephrol
, vol.17
, Issue.6
, pp. 1724-1734
-
-
Roos, A.1
Rastaldi, M.P.2
Calvaresi, N.3
-
68
-
-
84883647615
-
Glomerular mannose-binding lectin deposition is a useful prognostic predictor in immunoglobulin A nephropathy
-
Liu LL, Liu N, Chen Y, et al. Glomerular mannose-binding lectin deposition is a useful prognostic predictor in immunoglobulin A nephropathy. Clin Exp Immunol 2013;174(1):152-60
-
(2013)
Clin Exp Immunol
, vol.174
, Issue.1
, pp. 152-160
-
-
Liu, L.L.1
Liu, N.2
Chen, Y.3
-
69
-
-
84858668780
-
Membranoproliferative glomerulonephritis-a new look at an old entity
-
Sethi S, Fervenza FC. Membranoproliferative glomerulonephritis-a new look at an old entity. N Engl J Med 2012;366(12):1119-31
-
(2012)
N Engl J Med
, vol.366
, Issue.12
, pp. 1119-1131
-
-
Sethi, S.1
Fervenza, F.C.2
-
70
-
-
0027393927
-
Membranoproliferative glomerulonephritis associated with hepatitis C virus infection
-
Johnson RJ, Gretch DR, Yamabe H, et al. Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. N Engl J Med 1993;328(7):465-70
-
(1993)
N Engl J Med
, vol.328
, Issue.7
, pp. 465-470
-
-
Johnson, R.J.1
Gretch, D.R.2
Yamabe, H.3
-
71
-
-
77952300995
-
Membranoproliferative glomerulonephritis secondary to monoclonal gammopathy
-
Sethi S, Zand L, Leung N, et al. Membranoproliferative glomerulonephritis secondary to monoclonal gammopathy. Clin J Am Soc Nephrol 2010;5(5):770-82
-
(2010)
Clin J Am Soc Nephrol
, vol.5
, Issue.5
, pp. 770-782
-
-
Sethi, S.1
Zand, L.2
Leung, N.3
-
72
-
-
0347992788
-
Proliferative glomerulonephritis with monoclonal IgG deposits: A distinct entity mimicking immune-complex glomerulonephritis
-
Nasr SH, Markowitz GS, Stokes MB, et al. Proliferative glomerulonephritis with monoclonal IgG deposits: a distinct entity mimicking immune-complex glomerulonephritis. Kidney Int 2004;65(1): 85-96
-
(2004)
Kidney Int
, vol.65
, Issue.1
, pp. 85-96
-
-
Nasr, S.H.1
Markowitz, G.S.2
Stokes, M.B.3
-
73
-
-
84869779556
-
Monoclonal gammopathy of renal significance: When MGUS is no longer undetermined or insignificant
-
Leung N, Bridoux F, Hutchison CA, et al. Monoclonal gammopathy of renal significance: when MGUS is no longer undetermined or insignificant. Blood 2012; 120(22):4292-5
-
(2012)
Blood
, vol.120
, Issue.22
, pp. 4292-4295
-
-
Leung, N.1
Bridoux, F.2
Hutchison, C.A.3
-
74
-
-
69849086679
-
Proliferative glomerulonephritis with monoclonal IgG deposits
-
Nasr SH, Satoskar A, Markowitz GS, et al. Proliferative glomerulonephritis with monoclonal IgG deposits. J Am Soc Nephrol 2009;20(9):2055-64
-
(2009)
J Am Soc Nephrol
, vol.20
, Issue.9
, pp. 2055-2064
-
-
Nasr, S.H.1
Satoskar, A.2
Markowitz, G.S.3
-
75
-
-
84896701896
-
Membranoproliferative glomerulonephritis: The times they are a-changin
-
Cohen Tervaert JW. Membranoproliferative glomerulonephritis: the times they are a-changin. Clin Exp Nephrol 2014;18(1): 1-3
-
(2014)
Clin Exp Nephrol
, vol.18
, Issue.1
, pp. 1-3
-
-
Cohen Tervaert, J.W.1
-
76
-
-
84896695997
-
Membranoproliferative glomerulonephritis and circulating cryoglobulins
-
Hiramatsu R, Hoshino J, Suwabe T, et al. Membranoproliferative glomerulonephritis and circulating cryoglobulins. Clin Exp Nephrol 2014;18(1):88-94
-
(2014)
Clin Exp Nephrol
, vol.18
, Issue.1
, pp. 88-94
-
-
Hiramatsu, R.1
Hoshino, J.2
Suwabe, T.3
-
77
-
-
3042767356
-
Mixed cryoglobulinemia: Demographic, clinical, and serologic features and survival in 231 patients
-
Ferri C, Sebastiani M, Giuggioli D, et al. Mixed cryoglobulinemia: demographic, clinical, and serologic features and survival in 231 patients. Semin Arthritis Rheum 2004;33(6):355-74
-
(2004)
Semin Arthritis Rheum
, vol.33
, Issue.6
, pp. 355-374
-
-
Ferri, C.1
Sebastiani, M.2
Giuggioli, D.3
-
78
-
-
34648817584
-
Type ii cryoglobulinemia is not associated with hepatitis c infection: The dutch experience
-
Tervaert JW, Van Paassen P, Damoiseaux J. Type II cryoglobulinemia is not associated with hepatitis C infection: the Dutch experience. Ann N Y Acad Sci 2007;1107: 251-8
-
(2007)
Ann N y Acad Sci
, vol.1107
, pp. 251-258
-
-
Tervaert, J.W.1
Van Paassen, P.2
Damoiseaux, J.3
-
79
-
-
38749148451
-
A critical appraisal of current practice in the detection, analysis, and reporting of cryoglobulins
-
Vermeersch P, Gijbels K, Marien G, et al. A critical appraisal of current practice in the detection, analysis, and reporting of cryoglobulins. Clin Chem 2008;54(1):39-43
-
(2008)
Clin Chem
, vol.54
, Issue.1
, pp. 39-43
-
-
Vermeersch, P.1
Gijbels, K.2
Marien, G.3
-
80
-
-
84896313743
-
Diagnostics and treatment of cryoglobulinaemia: It takes two to tango
-
Damoiseaux J, Cohen Tervaert JW. Diagnostics and treatment of cryoglobulinaemia: it takes two to tango. Clin Rev Allergy Immunol 2014;47(3): 299-310
-
(2014)
Clin Rev Allergy Immunol
, vol.47
, Issue.3
, pp. 299-310
-
-
Damoiseaux, J.1
Cohen Tervaert, J.W.2
-
81
-
-
84871193435
-
Idiopathic membranoproliferative glomerulonephritis: Does it exist?
-
Fervenza FC, Sethi S, Glassock RJ. Idiopathic membranoproliferative glomerulonephritis: does it exist?. Nephrol Dial Transplant 2012;27(12):4288-94
-
(2012)
Nephrol Dial Transplant
, vol.27
, Issue.12
, pp. 4288-4294
-
-
Fervenza, F.C.1
Sethi, S.2
Glassock, R.J.3
-
82
-
-
0035810399
-
Complement. First of two parts
-
Walport MJ. Complement. First of two parts. N Engl J Med 2001;344(14):1058-66
-
(2001)
N Engl J Med
, vol.344
, Issue.14
, pp. 1058-1066
-
-
Walport, M.J.1
-
83
-
-
0035849176
-
Complement. Second of two parts
-
Walport MJ. Complement. Second of two parts. N Engl J Med 2001;344(15):1140-4
-
(2001)
N Engl J Med
, vol.344
, Issue.15
, pp. 1140-1144
-
-
Walport, M.J.1
-
84
-
-
84864554927
-
Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies
-
Servais A, Noel LH, Roumenina LT, et al. Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies. Kidney Int 2012; 82(4):454-64
-
(2012)
Kidney Int
, vol.82
, Issue.4
, pp. 454-464
-
-
Servais, A.1
Noel, L.H.2
Roumenina, L.T.3
-
85
-
-
77957827919
-
Human C3 mutation reveals a mechanism of dense deposit disease pathogenesis and provides insights into complement activation and regulation
-
Martinez-Barricarte R, Heurich M, Valdes-Canedo F, et al. Human C3 mutation reveals a mechanism of dense deposit disease pathogenesis and provides insights into complement activation and regulation. J Clin Invest 2010;120(10): 3702-12
-
(2010)
J Clin Invest
, vol.120
, Issue.10
, pp. 3702-3712
-
-
Martinez-Barricarte, R.1
Heurich, M.2
Valdes-Canedo, F.3
-
86
-
-
77956394517
-
Identification of a mutation in complement factor H-related protein 5 in patients of Cypriot origin with glomerulonephritis
-
Gale DP, De Jorge EG, Cook HT, et al. Identification of a mutation in complement factor H-related protein 5 in patients of Cypriot origin with glomerulonephritis. Lancet 2010;376(9743):794-801
-
(2010)
Lancet
, vol.376
, Issue.9743
, pp. 794-801
-
-
Gale, D.P.1
De Jorge, E.G.2
Cook, H.T.3
-
87
-
-
84868585648
-
Sensitive and specific assays for C3 nephritic factors clarify mechanisms underlying complement dysregulation
-
Paixao-Cavalcante D, Lopez-Trascasa M, Skattum L, et al. Sensitive and specific assays for C3 nephritic factors clarify mechanisms underlying complement dysregulation. Kidney Int 2012;82(10): 1084-92
-
(2012)
Kidney Int
, vol.82
, Issue.10
, pp. 1084-1092
-
-
Paixao-Cavalcante, D.1
Lopez-Trascasa, M.2
Skattum, L.3
-
88
-
-
84863115476
-
Causes of alternative pathway dysregulation in dense deposit disease
-
Zhang Y, Meyer NC, Wang K, et al. Causes of alternative pathway dysregulation in dense deposit disease. Clin J Am Soc Nephrol 2012;7(2):265-74
-
(2012)
Clin J Am Soc Nephrol
, vol.7
, Issue.2
, pp. 265-274
-
-
Zhang, Y.1
Meyer, N.C.2
Wang, K.3
-
89
-
-
80052573272
-
Glomerulonephritis with isolated C3 deposits and monoclonal gammopathy a fortuitous association?
-
Bridoux F, Desport E, Fremeaux-Bacchi V, et al. Glomerulonephritis with isolated C3 deposits and monoclonal gammopathy: a fortuitous association?. Clin J Am Soc Nephrol 2011;6(9):2165-74
-
(2011)
Clin J Am Soc Nephrol
, vol.6
, Issue.9
, pp. 2165-2174
-
-
Bridoux, F.1
Desport, E.2
Fremeaux-Bacchi, V.3
-
91
-
-
84906077328
-
Syndromes of thrombotic microangiopathy
-
George JN, Nester CM. Syndromes of thrombotic microangiopathy. N Engl J Med 2014;371(7):654-66
-
(2014)
N Engl J Med
, vol.371
, Issue.7
, pp. 654-666
-
-
George, J.N.1
Nester, C.M.2
-
92
-
-
34250329129
-
Spontaneous hemolytic uremic syndrome triggered by complement factor H lacking surface recognition domains
-
Pickering MC, De Jorge EG, Martinez-Barricarte R, et al. Spontaneous hemolytic uremic syndrome triggered by complement factor H lacking surface recognition domains. J Exp Med 2007; 204(6):1249-56
-
(2007)
J Exp Med
, vol.204
, Issue.6
, pp. 1249-1256
-
-
Pickering, M.C.1
De Jorge, E.G.2
Martinez-Barricarte, R.3
-
93
-
-
84884308134
-
Estimating renal survival using the ANCA-associated GN classification
-
Hilhorst M, Wilde B, van Breda Vriesman P, et al. Estimating renal survival using the ANCA-associated GN classification. J Am Soc Nephrol 2013; 24(9):1371-5
-
(2013)
J Am Soc Nephrol
, vol.24
, Issue.9
, pp. 1371-1375
-
-
Hilhorst, M.1
Wilde, B.2
Van Breda Vriesman, P.3
-
94
-
-
15144339407
-
Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis ec/bcr project for anca assay standardization
-
Hagen EC, Daha MR, Hermans J, et al. Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Project for ANCA Assay Standardization. Kidney Int 1998;53(3):743-53
-
(1998)
Kidney Int
, vol.53
, Issue.3
, pp. 743-753
-
-
Hagen, E.C.1
Daha, M.R.2
Hermans, J.3
-
95
-
-
84871641115
-
Antineutrophil cytoplasmic autoantibodies: How are they detected and what is their use for diagnosis, classification and follow-up?
-
Cohen Tervaert JW, Damoiseaux J. Antineutrophil cytoplasmic autoantibodies: how are they detected and what is their use for diagnosis, classification and follow-up?. Clin Rev Allergy Immunol 2012;43(3): 211-19
-
(2012)
Clin Rev Allergy Immunol
, vol.43
, Issue.3
, pp. 211-219
-
-
Cohen Tervaert, J.W.1
Damoiseaux, J.2
-
96
-
-
84923327980
-
ANCA as a predictor of relapse: Useful in patients with renal involvement but not in patients with nonrenal disease
-
Epub ahead of print
-
Kemna MJ, Damoiseaux J, Austen J, et al. ANCA as a predictor of relapse: useful in patients with renal involvement but not in patients with nonrenal disease. J Am Soc Nephrol 2014. [Epub ahead of print
-
(2014)
J Am Soc Nephrol
-
-
Kemna, M.J.1
Damoiseaux, J.2
Austen, J.3
-
97
-
-
32544444877
-
Systemic lupus erythematosus in europe at the change of the millennium: Lessons from the euro- lupus project
-
Cervera R, Abarca-Costalago M, Abramovicz D, et al. Systemic lupus erythematosus in Europe at the change of the millennium: lessons from the Euro- Lupus Project. Autoimmun Rev 2006;5(3): 180-6
-
(2006)
Autoimmun Rev
, vol.5
, Issue.3
, pp. 180-186
-
-
Cervera, R.1
Abarca-Costalago, M.2
Abramovicz, D.3
-
98
-
-
0942265440
-
The classification of glomerulonephritis in systemic lupus erythematosus revisited
-
Weening JJ, DAgati VD, Schwartz MM, et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol 2004;15(2):241-50
-
(2004)
J Am Soc Nephrol
, vol.15
, Issue.2
, pp. 241-250
-
-
Weening, J.J.1
Dagati, V.D.2
Schwartz, M.M.3
-
99
-
-
0020644042
-
Pathologic differentiation between lupus and nonlupus membranous glomerulopathy
-
Jennette JC, Iskandar SS, Dalldorf FG. Pathologic differentiation between lupus and nonlupus membranous glomerulopathy. Kidney Int 1983;24(3):377-85
-
(1983)
Kidney Int
, vol.24
, Issue.3
, pp. 377-385
-
-
Jennette, J.C.1
Iskandar, S.S.2
Dalldorf, F.G.3
-
101
-
-
84912105289
-
Clinical immunology - Autoimmunity in the Netherlands
-
2PB
-
Tervaert JW, Kallenberg CG. Clinical immunology - Autoimmunity in the Netherlands. Immunol Lett 2014;162(2PB): 134-40
-
(2014)
Immunol Lett
, vol.162
, pp. 134-140
-
-
Tervaert, J.W.1
Kallenberg, C.G.2
-
102
-
-
4944245001
-
Anti-C1q autoantibodies deposit in glomeruli but are only pathogenic in combination with glomerular C1q-containing immune complexes
-
Trouw LA, Groeneveld TW, Seelen MA, et al. Anti-C1q autoantibodies deposit in glomeruli but are only pathogenic in combination with glomerular C1q-containing immune complexes. J Clin Invest 2004;114(5):679-88
-
(2004)
J Clin Invest
, vol.114
, Issue.5
, pp. 679-688
-
-
Trouw, L.A.1
Groeneveld, T.W.2
Seelen, M.A.3
-
103
-
-
84865708432
-
Combination of anti-C1q and anti-dsDNA antibodies is associated with higher renal disease activity and predicts renal prognosis of patients with lupus nephritis
-
Yang XW, Tan Y, Yu F, et al. Combination of anti-C1q and anti-dsDNA antibodies is associated with higher renal disease activity and predicts renal prognosis of patients with lupus nephritis. Nephrol Dial Transplant 2012;27(9):3552-9
-
(2012)
Nephrol Dial Transplant
, vol.27
, Issue.9
, pp. 3552-3559
-
-
Yang, X.W.1
Tan, Y.2
Yu, F.3
|